Most Popular

    Sorry. No data so far.


Winner of Amgen Patients | Choices | Empowerment Competition Emerging Star of HealthCare Engagement Award
Mayo Clinic Award - LeftA winner of the Mayo Clinic iSpot Competition for Ideas that will Transform HealthcareMayo Clinic Award - R

New Research Partner: MIT Media Lab

April 28th, 2011 Alexandra Carmichael Posted in Open Source Research, Random Company News No Comments »

We are excited to welcome Ian Eslick of MIT Media Lab to our research partners! Ian is studying collective self-experimentation and treatment recommendations, and will access subsets of CureTogether’s data to assist with his research.

CureTogether actively partners with academic researchers who approach us about studying our data. We believe having more minds looking at the data will only accelerate discovery, as each researcher brings their own approach and interest to the data analysis.

Our current research partnerships include, in alphabetical order by institution:

Carnegie Mellon University
Kateryna Kuksenok and Jen Mankoff
Dynamic filtering visualization of CureTogether data (in progress)


Drexel University

Will Dampier
Building an adaptive recommendation system for treatments (in progress)


Emory University

Adam Sperduto and Suephy Chen
Feasibility and Reliability of Internet Crowdsourcing Data Collection with Dermatologic Quality of Life Assessment Tools


MIT Media Laboratory
Ian Eslick
Collective self-experimentation and recommendations (in progress)


Stanford University
Diana MacLean and Jeff Heer
Analysis and visualization of community dynamics and data over time (in progress)


Transparency Life Sciences
Tomasz Sablinski
Open Source Clinical Trial on Low-Dose Naltrexone


University of California Davis
April W. Armstrong, MD MPH
Personalized Therapeutics and Evaluation of Treatment Responses in Skin Diseases from Patient-Driven Data (in progress)


If you are a researcher interested in working with CureTogether’s data for your project, please let us know.

AddThis Social Bookmark Button

How CureTogether is Unique

September 29th, 2010 Alexandra Carmichael Posted in Open Source Research, Perspective 1 Comment »

I get this question so often that I thought I’d just write it up in a post, so here goes!

What makes CureTogether unique?

1. Quantitative Crowdsourcing.

CureTogether is about quantifying the collective patient experience. While most other patient support sites have focused on stories or information from experts, we focus on quantitative data across over 600 patient-contributed conditions. Individual data is kept private, but the anonymized aggregate data is shared openly to maximize discoveries that can be made.

2. Open Infographics.

At over 1 million data points, CureTogether has the largest available real-world comparative effectiveness database available to patients online. It’s deep knowledge shared from individual patient experiences, elevating global patient voices in a way that has never been done before. We help patients learn what treatments are available for their condition (based on what others are trying), and how popular and effective each treatment is reported to be. Patients can also track any measures of their health over time, recording weight, stress levels, pain, mood, and share this information with their doctors.

3. Breaking Isolation.

CureTogether also helps people find and connect with others with whom they share multiple health conditions, which would otherwise be extremely difficult since most health sites are organized around individual conditions. Imagine finding someone who shares 7 conditions with you and being able to ask them private questions.

4. Novel Discoveries.

Finally, we have unique data on co-morbidities. We’ve been able to replicate an association between infertility and asthma (and dozens of other conditions) using only patient-contributed data. As more patients add their voices, we will be able to give more personalized information about what might work for whom.

Patients are helping each other, helping research go forward into their conditions, and helping themselves.

I hope that answers the question!

AddThis Social Bookmark Button

New Study: Low-Dose Naltrexone

September 13th, 2010 Alexandra Carmichael Posted in Open Source Research 21 Comments »

Life science research should be transparent.

This is exciting news. CureTogether is partnering with Transparency Life Sciences to run a trial on Low-Dose Naltrexone (LDN). Read the letter below for details.

“Dear CureTogether and LDN community members,
If you use or prescribe Low-Dose Naltrexone, we would like to invite you to share your experience and be part of a new kind of participatory research. LDN is currently used “off-label” by thousands of patients worldwide who are inconvenienced and frustrated by the lack of regulatory and marketing authorization of this medication. A start-up drug development company, Transparency Life Sciences (TLS), is interested in performing open clinical trials on LDN for several conditions, if we get enough interest from patients, health care providers, and funders.
Your voice is important in making this happen, so that LDN can be properly studied. As a first step we suggest you visit CureTogether, a consumer driven Health 2.0 company that brings patients with hundreds of conditions together in overlapping data communities, to share and learn from each other privately. We invite you to anonymously answer a few questions about your symptoms and treatments on CureTogether’s LDN condition pages. This contribution to the community will allow TLS to assess the potential interest in LDN clinical studies, and decide which condition to study first.

If we have enough initial interest, we will reach out to the CureTogether and LDN communities again to design and participate in these open source clinical studies that will be based on outcomes that are meaningful to you, not just ones that are essential for regulatory approvals.

Thank you for being a part of changing how research is done, and helping research go forward on LDN.
Best regards,
Tomasz Sablinski, Founder of Transparency Life Sciences
Daniel Reda, Co-Founder of CureTogether”
Be part of this research by participating in one of the condition surveys listed at our LDN condition pages. Thank you!
AddThis Social Bookmark Button

The Skin Disease Race is ON!

July 19th, 2010 Alexandra Carmichael Posted in Open Source Research, Random Company News 1 Comment »

Do you have a skin disease? If you do, please join the race.

CureTogether is excited to announce a new research project we’re collaborating on. Researchers Suephy Chen, Adam Sperduto, and Bob Swerlick at Emory University are doing a study to compare whether online recruiting methods can beat their traditional in-clinic recruiting methods.

Basically, they want to see whether CureTogether or in-person methods can get more people to answer a skin disease survey. Here’s your chance to help show the power of online communities.

“Please click here if you have been diagnosed with eczema/atopic dermatitis, seborrheic dermatitis, psoriasis, rosacea, or acne and would like to learn more about participating in a clinic research study conducted by the Emory University School of Medicine Department of Dermatology. Thank you!”

We’ll keep you posted on how the race goes!

AddThis Social Bookmark Button

New: Online Autism Treatment Study

April 27th, 2010 Alexandra Carmichael Posted in Condition Awareness, Open Source Research, Random Company News No Comments »

This press release went out this morning:

CureTogether, an online social health community, announced today the launch of its Autism treatment study. CureTogether will provide an online venue for parents with Autistic children to anonymously share and rate the success of their treatments.

“CureTogether is here to do good; we’ve adopted an open-source philosophy for health research,” said CureTogether co-founder Daniel Reda. “Patients and parents have so much knowledge and expertise to share with each other and with the world.”

CureTogether is interested in collecting information about any and all treatments tried including: Anxiety and Depression medications, Chelation and IV therapies, Glutathione, Naltrexone, EDTA, DMPS, DMSA, Detoxification, vitamins B-12, B-6, supplements, Gluten-Free and Casein-Free Diets, Hyperbaric Oxygen Treatments, Stem Cell Therapy, Play Therapy, Music Therapy, etc.

The CureTogether website also allows patients and parents to add therapies that may not be listed. CureTogether’s goal is to provide data back to the Autism community as to the most effective treatment options. Curetogether is completely impartial and not affiliated with any pharmaceutical or healthcare supplier.

Please visit http://www.curetogether.com/autism to participate in the study.

About Autism
Autism is a complex developmental disability that typically appears during the first three years of life and affects a person’s ability to communicate and interact with others. Autism is defined by a certain set of behaviors and is a “spectrum disorder” that affects individuals differently and to varying degrees. There is no known single cause for Autism. According to the Centers for Disease Control and Prevention, 1 in every 110 births in the United States and almost 1 in 70 boys is affected by Autism.

About CureTogether, Inc.
CureTogether is a website that helps people anonymously track and compare health data, to better understand their bodies, make more informed treatment decisions and contribute data to research. CureTogether has been featured in Wired (“Empowering Patients”), The New York Times, The Wall Street Journal, and BusinessWeek (“Innovative”). For more information, please visit www.curetogether.com/blog/about or send an email to press(at)curetogether(dot)com.

AddThis Social Bookmark Button

Depression-Insomnia Link Reported at CureTogether

October 30th, 2009 Alexandra Carmichael Posted in Open Source Research, Research Findings 3 Comments »

CureTogether Data Finds Link Between Self-Reported Depression and Insomnia

Patients at CureTogether (http://www.curetogether.com) who report depression are twice as likely to report insomnia than patients with no depression. This is among the first self-reported data that reproduces findings previously done in slow, expensive clinical research. It comes from an analysis of 761 patients, and is being released in conjunction with the TEDMED and BIL:PIL conferences this week – please see the chart, and details below.
.

Picture 4

Chart: Patients with depression are more likely to report insomnia than patients with no depression. From patient self-reported data at CureTogether.
.

Details of the CureTogether Finding… Read the rest of this entry »

AddThis Social Bookmark Button

The Patient Decision Cycle

October 24th, 2009 Alexandra Carmichael Posted in Open Source Research 5 Comments »

How can patients’ decisions be optimized? I didn’t know, but I was determined to find out. At a recent Stanford MediaX workshop on Augmented Decision Environments that I was lucky enough to attend, Neil Jacobstein described a continuously improving decision cycle used by the military and based on over 50 years of decision theory.

The steps of the cycle? Read the rest of this entry »

AddThis Social Bookmark Button

Crowdsourced Health Finds Infertility-Asthma Link

September 15th, 2009 Alexandra Carmichael Posted in Open Source Research, Research Findings 3 Comments »

CureTogether Data Reveals Link Between Self-Reported Infertility and Asthma
——————————————————————————————————————–

Announced at Mayo Clinic Transforming Healthcare Conference on September 15: Patients at CureTogether who report infertility are 1.9x more likely to report having asthma than patients who don’t report infertility.

This comes from an analysis of 324 patients… Read the rest of this entry »

AddThis Social Bookmark Button

Top 6 Upcoming Health Events

May 18th, 2009 Alexandra Carmichael Posted in Events, Open Source Research 1 Comment »

The air is buzzing. People are talking about health more than ever before, and it’s good news for patients. Technology is making it possible for patients to take an active role in “participatory medicine”, partnering with their doctors to decide on the best course of action for their health.

Over the next few months, these 6 events will bring together patients, researchers, doctors, and health enthusiasts. Discussions, partnerships, and innovations will emerge. Keep your eye on these, and attend if you can!

.

1. TEDMED – October 27-30, http://www.tedmed.comtedmed-logo2
The medical version of the legendary TED conferences. From the TEDMED site: “The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED celebrates conversations that demonstrate the intersection and connections between all things medical and healthcare related: from personal health to public health, devices to design and Hollywood to the hospital.” This year’s speakers include Dean Kamen, Craig Venter, Sanjay Gupta and Goldie Hawn.

.

2. Transform – September 13-15, http://centerforinnovation.mayo.edu/transformpicture-4
A collaborative symposium at The Mayo Clinic Center for Innovation. From the Transform site: “Transform brings together a dynamic group of speakers and participants from inside and outside the health care industry to explore the intersections between human experience, health care delivery and new business models. Join us to imagine and create innovative ways to deliver a better health care experience in a 21st century world.”

.

3. Health 2.0 – October 6-7, http://www.health2con.compicture-5
Next-generation health companies and patient advocates converge. From the Health 2.0 site: “With more than a hundred speakers and hundreds of new healthcare demos and technologies on display on stage and in the exhibit hall, you’ll get a sweeping overview of the ways that information technology and the web are changing healthcare in areas from online search to health focused online communities and social networks.”

.

4. Web Strategies for Health Communication – July 19-24, http://webstrategiesforhealth.compicture-6
A new course by Dr. Lisa Gualtieri at Tufts University School of Medicine. From the Web Strategies site: “The Summer Institute on Web Strategies for Health Communication covers how to develop and implement a Web strategy to drive a health organization’s online presence, specifically the processes for selecting, using, managing, and evaluating the effectiveness of Web technologies for health communication.”

.

5. Singularity University – July-August, http://singularityu.orgpicture-3
Graduate studies program started by Ray Kurzweil and Peter Diamandis. From the Singularity University site: “Singularity University aims to assemble, educate and inspire a cadre of leaders who strive to understand and facilitate the development of exponentially advancing technologies and apply, focus and guide these tools to address humanity’s grand challenges.” Biotechnology and Medicine are two of the tracks they offer.

.

6. Regenstrief Conference – Sept 23-35, http://www.regenstrief.org/conferences/2009picture-7
An invitation-only unconference, but one to watch. From the Regenstrief site: “The theme for this year’s conference is Open Health Methodologies. Participants include: Clay Shirky (open source), Dr. Roni Zeiger (Google Health), and Mark Surman (Mozilla).”

.

If you aren’t able to attend, let us know what you think are the most important issues in health today and we’ll make sure to represent your ideas. Good things will come from all the buzz – the future of health care and health research is bright.

AddThis Social Bookmark Button

Tim Ferriss and Kevin Rose on Open Source Clinical Trials

May 15th, 2009 Alexandra Carmichael Posted in Open Source Research, Presentations, Random Company News 1 Comment »

The second video in a series of two famous buddies discussing random things, in the clip below Tim and Kevin talk about music, open source clinical trials, CureTogether (about half way through), and their favorite knives. The open source health discussion is impressive, the rest is good fun. And check out Tim’s shoes!

.

Random Episode Numero 2 from Glenn McElhose on Vimeo.

AddThis Social Bookmark Button